BRIEF published on 07/09/2026 at 10:05, 1 month 14 days ago Axxam and HeartBeat.bio Form Partnership for Cardiovascular Drug Innovation New Approach Methodologies Cardiovascular Drug Discovery Cardiac Safety Assessment Human Cardiac Organoids Drug Discovery Collaboration
BRIEF published on 07/09/2026 at 10:05, 1 month 14 days ago Axxam et HeartBeat.bio s'associent pour l'innovation dans le domaine des médicaments cardiovasculaires Nouvelles Méthodologies D'approche Découverte De Médicaments Cardiovasculaires Évaluation De La Sécurité Cardiaque Organoïdes Cardiaques Humains Collaboration En Matière De Découverte De Médicaments
PRESS RELEASE published on 07/09/2026 at 10:00, 1 month 14 days ago Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment Axxam and HeartBeat.bio form strategic partnership to enhance cardiovascular drug discovery and safety assessment with human cardiac organoid technology Partnership Axxam HeartBeat.bio Cardiovascular Drug Discovery Human Cardiac Organoid
BRIEF published on 09/23/2025 at 10:05, 11 months ago HeartBeat.bio Collaborates with Boehringer Ingelheim on Gene Therapies Cardiovascular Health Research Collaboration Gene Therapies Heart Muscle Disorders Cardioid Platform
BRIEF published on 09/23/2025 at 10:05, 11 months ago HeartBeat.bio collabore avec Boehringer Ingelheim sur les thérapies géniques Santé Cardiovasculaire Collaboration En Recherche Thérapies Géniques Troubles Du Muscle Cardiaque Plateforme Cardioïde
PRESS RELEASE published on 09/23/2025 at 10:00, 11 months ago HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders HeartBeat.bio collaborates with Boehringer Ingelheim to develop gene therapies for genetic cardiomyopathies, addressing unmet needs in heart health Heart Health Gene Therapy Boehringer Ingelheim HeartBeat.bio Cardiomyopathies
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 9 months ago HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
Published on 08/24/2026 at 07:45, 2 hours 12 minutes ago Sinopec Achieves Solid Operating Results in the First Half of 2026
Published on 08/22/2026 at 05:50, 2 days 4 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 2 days 5 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 2 days 9 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 2 days 10 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/24/2026 at 09:35, 22 minutes ago 2026 Taiwan Jewellery & Gem Fair to Take Place in November
Published on 08/24/2026 at 09:00, 56 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): Under review
Published on 08/24/2026 at 08:56, 1 hour ago IBU-tec fully on track in the first half of 2026 / Focus on capacity build-up for large LFP plant
Published on 08/21/2026 at 18:33, 2 days 15 hours ago 260821 BENETEAU Transaction sur actions propres
Published on 08/18/2026 at 18:00, 5 days 15 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 5 days 16 hours ago Mise à disposition du rapport financier annuel 2025-26
